Clinical Trial

Trial Protocol ID APL-101-01_SPARTA

Trial Description

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met Exon 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Kashif Ali, MD

Sponsor

  • Apollomics, Inc.

ClinicalTrials.gov NCT ID

  • NCT03175224